For the purposes of ASX Listing Rule 17.1 and in support of its request, the Company advises that:
1. The trading halt is requested pending an announcement to the market in relation to assay results from
2. The Company expects the trading halt to remain in place until the earlier of the time it makes an announcement to the market of the results or the commencement of trading on
3. The Company is not aware of any reason why the request for the trading halt should not be granted or any other information necessary to inform the market regarding the trading halt.
This request has been authorised by the board of directors of the Company.
Contact:
Non-Executive Director and Company Secretary
T: +61 8 6241 1877
(C) 2022 Electronic News Publishing, source